-
Mashup Score: 3JCI - Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19 - 3 year(s) ago
Clinical MedicineVirology Free access | 10.1172/JCI151697 Colin F. Pawlowski,2 John C. O’Horo,1 Lori L. Arndt,3 Richard F. Arndt,3 Sarah J. Bell,1 Dennis M. Bierle,1 Molly Destro Borgen,1 Sara N. Hanson,4 Alexander Heyliger,1 Jennifer J. Larsen,1 Patrick J. Lenehan,2 Robert Orenstein,5…
Source: www.jci.orgCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0JCI - Promoting the success of women and minority physician-scientists in academic medicine: a dean’s perspective - 3 year(s) ago
To address behaviors such as sexual harassment and racism, leaders in academic medicine must hold people accountable, regardless of rank or position. Systems for reporting and for investigation of cases of sexual harassment or racism must be in place a priori, and alleged cases must be investigated confidentially, expeditiously, and fairly. Because many of our faculty members and trainees…
Source: www.jci.orgCategories: Cardiologists, Latest HeadlinesTweet-
An important priority for #NewYear2021: Promoting the #success of #women and #minority clinician-scientists in #academic medicine. Read one university dean's perspective. https://t.co/t1gaYbcn5J #disparities @nih @NIH_ORWH @NIH_COSWD #mentoring #career #JCI @NIHFunding https://t.co/XWfZo5diKu
-
#JCI - #bamlanivimab associates with reduced #hospitalization, ICU admission and mortality in >4600 high-risk patients with mild to moderate #COVID19 @jclinicalinvest @MayoClinicINFD @MayoClinic https://t.co/3uVdljiKTI